{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:38:20Z","timestamp":1789706300812,"version":"4.0.1"},"reference-count":57,"publisher":"American Society for Clinical Investigation","issue":"7","license":[{"start":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T00:00:00Z","timestamp":1599436800000},"content-version":"vor","delay-in-days":886,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Cancer Institute","award":["NCI 5R03CA205713"],"award-info":[{"award-number":["NCI 5R03CA205713"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,5]]},"abstract":"<jats:p>We generated a comprehensive atlas of the immunologic cellular networks within human malignant pleural mesothelioma (MPM) using mass cytometry. Data-driven analyses of these high-resolution single-cell data identified 2 distinct immunologic subtypes of MPM with vastly different cellular composition, activation states, and immunologic function; mass spectrometry demonstrated differential abundance of MHC-I and -II neopeptides directly identified between these subtypes. The clinical relevance of this immunologic subtyping was investigated with a discriminatory molecular signature derived through comparison of the proteomes and transcriptomes of these 2 immunologic MPM subtypes. This molecular signature, representative of a favorable intratumoral cell network, was independently associated with improved survival in MPM and predicted response to immune checkpoint inhibitors in patients with MPM and melanoma. These data additionally suggest a potentially novel mechanism of response to checkpoint blockade: requirement for high measured abundance of neopeptides in the presence of high expression of MHC proteins specific for these neopeptides.<\/jats:p>","DOI":"10.1172\/jci.insight.98575","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T11:00:55Z","timestamp":1522839655000},"source":"Crossref","is-referenced-by-count":50,"title":["Comprehensive immunoproteogenomic analyses of malignant pleural mesothelioma"],"prefix":"10.1172","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8259-046X","authenticated-orcid":true,"given":"Hyun-Sung","family":"Lee","sequence":"first","affiliation":[{"name":"Division of Thoracic Surgery, Michael E. DeBakey Department of Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hee-Jin","family":"Jang","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Michael E. DeBakey Department of Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Min","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Section of Hematology-Oncology, Department of Medicine,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica Lenge","family":"de Rosen","sequence":"additional","affiliation":[{"name":"Department of Radiology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Wheeler","sequence":"additional","affiliation":[{"name":"Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5666-9753","authenticated-orcid":true,"given":"Ju-Seog","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Systems Biology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuydung","family":"Tu","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplantation, Immune Evaluation Laboratory, Michael E. DeBakey Department of Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter T.","family":"Jindra","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplantation, Immune Evaluation Laboratory, Michael E. DeBakey Department of Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald H.","family":"Kerman","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplantation, Immune Evaluation Laboratory, Michael E. DeBakey Department of Surgery, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1521-7977","authenticated-orcid":true,"given":"Sung Yun","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrah","family":"Kheradmand","sequence":"additional","affiliation":[{"name":"Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas, USA."},{"name":"Department of Medicine, Baylor College of Medicine, Houston, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Sugarbaker","sequence":"additional","affiliation":[{"name":"Center for Translational Research in Inflammatory Diseases, Michael E. DeBakey VA Medical Center, Houston, Texas, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan M.","family":"Burt","sequence":"additional","affiliation":[{"name":"Division of Thoracic Surgery, Michael E. DeBakey Department of Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2018,4,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/jso.1143"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)01238-6"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000000903"},{"key":"B4","doi-asserted-by":"crossref","first-page":"S292","DOI":"10.1016\/j.jtho.2016.11.300","article-title":"A phase II study of nivolumab in malignant pleural mesothelioma (NivoMes): with translational research (TR) biopsies","volume":"12","author":"Quispel-Janssen","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B5","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1016\/j.jtho.2016.11.301","article-title":"Phase II trial of pembrolizumab in patients with malignant mesothelioma (MM): interim analysis","volume":"12","author":"Kindler","year":"2017","journal-title":"J Thorac Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30169-9"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606774"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1126\/science.aan6733"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.26143"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2015.1009285"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.04.016"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.07.024"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.04.014"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2987-0_8"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.12.022"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1126\/science.1259425"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500633"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2014.998538"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1172\/JCI87324"},{"key":"B20","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10582","article-title":"Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1\/PD-L1 therapy","volume":"7","author":"Johnson","year":"2016","journal-title":"Nat Commun"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/eji.200425587"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406498"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0095"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaa1348"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf1490"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/nature13988"},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13404","article-title":"Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry","volume":"7","author":"Bassani-Sternberg","year":"2016","journal-title":"Nat Commun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-016-0333-9"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.3384"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-017-0408-2"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4161\/onci.21511"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.11.006"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3520"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1038\/ng.855"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkw1121"},{"key":"B36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2017.00278","article-title":"The Immune Epitope Database and Analysis Resource in Epitope Discovery and Synthetic Vaccine Design","volume":"8","author":"Fleri","year":"2017","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1110\/ps.0239403"},{"issue":"Web Server issue","key":"B38","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkn202","article-title":"NetMHC-3.0: accurate web accessible predictions of human, mouse and monkey MHC class I affinities for peptides of length 8-11","volume":"36","author":"Lundegaard","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-11-568","article-title":"Peptide binding predictions for HLA DR, DP and DQ molecules","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1000048"},{"key":"B41","doi-asserted-by":"crossref","DOI":"10.1038\/srep31745","article-title":"Fine needle aspirate flow cytometric phenotyping characterizes immunosuppressive nature of the mesothelioma microenvironment","volume":"6","author":"Lizotte","year":"2016","journal-title":"Sci Rep"},{"key":"B42","doi-asserted-by":"crossref","DOI":"10.1038\/srep12298","article-title":"Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations","volume":"5","author":"Lesterhuis","year":"2015","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.02.065"},{"key":"B44","unstructured":"The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines):Malignant pleural mesothelioma (version 2.2017),. National Comprehensive Cancer Network. https:\/\/www.nccn.org\/professionals\/physician_gls\/f_guidelines.asp Accessed March 8, 2018"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf8399"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2014.12.033"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.01.014"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.154"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI80011"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1501824"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1200690"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1411087"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/nature13904"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/nature14011"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.12.019"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4051"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-17-0270"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/98575\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:02:32Z","timestamp":1779195752000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/98575"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,5]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,4,5]]},"published-print":{"date-parts":[[2018,4,5]]}},"alternative-id":["10.1172\/jci.insight.98575"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.98575","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,5]]},"article-number":"e98575"}}